3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
4
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
72
Lung Neoplasms
9
Adenocarcinoma of Lung
7
Brain Neoplasms
5
Non-squamous Non-small Cell Lung Cancer
4
NSCLC
4
Adenocarcinoma
4
Mesothelioma, Malignant
3
Colorectal Neoplasms
3
Nonsquamous Non-Small Cell Lung Cancer
2
Non-squamous Cell Non-Small Cell Lung Cancer
2
Neoplasms
2
Meningeal Carcinomatosis
2
Lymphoma
2
Glioma
2
Central Nervous System Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Untreated Advanced Non-Small Cell Lung Cancer
1
Unresectable Stage III NSCLC
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thoracic Neoplasms
1
Stomach Neoplasms
1
Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer
1
Staging IV NSCLC
1
Squamous Cell Lung Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Respiratory Tract Neoplasms
1
Interventions
Gemcitabine
7
Cystectomy
5
Cisplatin
5
durvalumab
4
Neoadjuvant Therapy
4
Mitomycin
4
atezolizumab
3
Transurethral Resection of Bladder
3
Nivolumab
3
Epirubicin
3
Chemoradiotherapy
3
BCG Vaccine
3
Anesthesia, Spinal
3
tislelizumab
2
disitamab vedotin
2
catumaxomab
2
Vitamin E
2
Urinary Diversion
2
Sunitinib
2
Selenium
2
Robotic Surgical Procedures
2
Multiparametric Magnetic Resonance Imaging
2
Magnetic Resonance Imaging
2
Immunohistochemistry
2
Fentanyl
2
Docetaxel
2
Diathermy
2
Cystoscopy
2
Chemoprevention
2
BCG Connaught
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Urinary Bladder Neoplasms
×
Pemetrexed
×
Clear all
NCT03193788
2017-06-21
PREMIER
Asan Medical Center
Phase 3
Unknown
74 enrolled